Arrakis Bio
Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.
About
Arrakis Bio bio-manufactures regenerative human biomaterials, starting with medical-grade human collagen. Their proprietary technology enables sustainable, scalable production of high-purity collagen for medical aesthetics, regenerative medicine, and biomedical research. Arrakis Bio aims to revolutionize the availability of these advanced biomaterials for a healthier and more beautiful future. Teams look it up for Life Sciences, Agritech, Food.
Frequently asked
What does Arrakis Bio do?
Arrakis Bio is a Life Sciences company that offers Platform. Teams look it up for Agritech, Food, Biotech. It is based in Cambridge, United States and was founded in 2019. Public records show about 5 people. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
Where is Arrakis Bio headquartered?
Arrakis Bio is headquartered in Cambridge, United States.
When was Arrakis Bio founded?
Arrakis Bio was founded in 2019.
What industry does Arrakis Bio operate in?
Arrakis Bio operates in Life Sciences, Agritech, Food, Biotech, MedTech.
How many employees does Arrakis Bio have?
Arrakis Bio has approximately 5 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.